Skip to main content
. 2024 Oct 24;131(11):1775–1780. doi: 10.1038/s41416-024-02885-3

Table 2.

Efficacy outcome

Variable No. of patients (n = 31) %
CR 0 0
PR 8 25.8
SD 21 67.7
PD 2 6.5
ORR, n (%) 8 25.8
DCR, n (%) 29 93.5
Six-month PFS rate, (%) 74.2
One-year OS rate, (%) 73.5
PFS, median (95%CI), months 9.2 (6.285–12.115)
OS, median (95%CI), months Not reached

CR Complete response, PR partial response, SD stable disease, PD progressive disease, PFS progression-free survival, OS overall survival, CI confidence interval, NR not reached